ERCC1 As A Prognostic Factor For Survival In Patients With Advanced Urothelial Cancer Treated With Platinum Based Chemotherapy: A Systematic Review And Meta-Analysis

The predictive role of excision repair cross-complementing group 1 (ERCC1) as a predictive factor in patients with advanced urothelial cancer (AUC) treated with platinum-based treatment is not well defined. Here, we evaluate the role of ERCC1 in patients with AUC treated with platinum-based treatment.

Source: Critical Reviews in Oncology Hematology - November 1, 2017 Category: Cancer & Oncology Authors: Yuksel Urun, Jeffrey J. Leow, Andre P. Fay, Laurence Albiges, Toni K. Choueiri, Joaquim Bellmunt Source Type: research